Bayer Suit Over Generic Yasmin Gets The Boot
A federal judge has ruled that Watson Pharmaceuticals Inc. and Sandoz Inc. won't infringe a Bayer AG patent by introducing a generic version of oral contraceptive Yasmin, saying the patent only...To view the full article, register now.
Already a subscriber? Click here to view full article